356 related articles for article (PubMed ID: 28864054)
1. Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions.
Ost DE; Niu J; Zhao H; Grosu HB; Giordano SH
Chest; 2018 Feb; 153(2):438-452. PubMed ID: 28864054
[TBL] [Abstract][Full Text] [Related]
2. Procedures Performed during Hospitalizations for Malignant Pleural Effusions: Data from the 2012 National Inpatient Sample.
Fortin M; Taghizadeh N; Tremblay A
Respiration; 2018; 95(4):228-234. PubMed ID: 29414821
[TBL] [Abstract][Full Text] [Related]
3. The Clinical and Economic Implications of Different Treatment Pathways for Patients with Rapidly Recurrent Malignant Pleural Effusion.
Ost DE; Goldblatt C; Jung M; Weiss M; Xu S; Taneja A; Erdal E
Chest; 2024 Jun; ():. PubMed ID: 38838953
[TBL] [Abstract][Full Text] [Related]
4. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in pleurodesis for malignant pleural disease.
Guinde J; Georges S; Bourinet V; Laroumagne S; Dutau H; Astoul P
Clin Respir J; 2018 Oct; 12(10):2463-2468. PubMed ID: 30252207
[TBL] [Abstract][Full Text] [Related]
6. Update on the diagnosis and management of malignant pleural effusions.
Bashour SI; Mankidy BJ; Lazarus DR
Respir Med; 2022 May; 196():106802. PubMed ID: 35287006
[TBL] [Abstract][Full Text] [Related]
7. Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience.
Bertolaccini L; Viti A; Gorla A; Terzi A
Eur J Surg Oncol; 2012 Dec; 38(12):1161-4. PubMed ID: 22959168
[TBL] [Abstract][Full Text] [Related]
8. Resource Use and Costs of Indwelling Pleural Catheters versus Pleurodesis for Malignant Pleural Effusions: A Population-based Study.
Kwok C; Thavorn K; Amjadi K; Aaron SD; Kendzerska T
Ann Am Thorac Soc; 2024 Jun; 21(6):940-948. PubMed ID: 38381853
[No Abstract] [Full Text] [Related]
9. Comparing approaches to the management of malignant pleural effusions.
Porcel JM; Lui MM; Lerner AD; Davies HE; Feller-Kopman D; Lee YC
Expert Rev Respir Med; 2017 Apr; 11(4):273-284. PubMed ID: 28271728
[TBL] [Abstract][Full Text] [Related]
10. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions.
Crnjac A
Wien Klin Wochenschr; 2004; 116 Suppl 2():28-32. PubMed ID: 15506307
[TBL] [Abstract][Full Text] [Related]
11. Malignant Pleural Effusions.
Kapp CM; Lee HJ
Clin Chest Med; 2021 Dec; 42(4):687-696. PubMed ID: 34774175
[TBL] [Abstract][Full Text] [Related]
12. Malignant pleural effusions: management options with consideration of coding, billing, and a decision approach.
Haas AR; Sterman DH; Musani AI
Chest; 2007 Sep; 132(3):1036-41. PubMed ID: 17873197
[TBL] [Abstract][Full Text] [Related]
13. Experience with indwelling pleural catheters in the treatment of recurrent pleural effusions.
Chalhoub M; Ali Z; Sasso L; Castellano M
Ther Adv Respir Dis; 2016 Dec; 10(6):566-572. PubMed ID: 27655919
[TBL] [Abstract][Full Text] [Related]
14. Early Readmission to Hospital in Patients With Cancer With Malignant Pleural Effusions: Analysis of the Nationwide Readmissions Database.
Mitchell MA; Dhaliwal I; Mulpuru S; Amjadi K; Chee A
Chest; 2020 Feb; 157(2):435-445. PubMed ID: 31542449
[TBL] [Abstract][Full Text] [Related]
15. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
[TBL] [Abstract][Full Text] [Related]
16. Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion.
Mercer RM; Varatharajah R; Shepherd G; Lu Q; Castro-Añón O; McCracken DJ; Dudina A; Addala D; Tsikrika S; George V; Banka R; Asciak R; Hassan M; Hallifax R; Bedawi EO; Shute JK; Rahman NM
BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32963027
[TBL] [Abstract][Full Text] [Related]
17. Interventional therapies for malignant pleural effusions: the present and the future.
Thomas R; Francis R; Davies HE; Lee YC
Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955
[TBL] [Abstract][Full Text] [Related]
18. Contemporary best practice in the management of malignant pleural effusion.
Koegelenberg CFN; Shaw JA; Irusen EM; Lee YCG
Ther Adv Respir Dis; 2018; 12():1753466618785098. PubMed ID: 29952251
[TBL] [Abstract][Full Text] [Related]
19. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
20. Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion.
Fysh ETH; Bielsa S; Budgeon CA; Read CA; Porcel JM; Maskell NA; Lee YCG
Chest; 2015 Jun; 147(6):1629-1634. PubMed ID: 25474713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
